Elanco Animal Health Stock Today
| ELAN Stock | USD 14.43 0.15 1.05% |
PerformanceGood
| Odds Of DistressLow
|
Elanco Animal is selling at 14.43 as of the 3rd of July 2025; that is 1.05 percent increase since the beginning of the trading day. The stock's open price was 14.28. Elanco Animal has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 4th of April 2025 and ending today, the 3rd of July 2025. Click here to learn more.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. Elanco Animal operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. The company has 496.65 M outstanding shares of which 24.28 M shares are currently shorted by private and institutional investors with about 4.03 trading days to cover. More on Elanco Animal Health
Moving together with Elanco Stock
| 0.82 | VTRS | Viatris Aggressive Push | PairCorr |
Moving against Elanco Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Elanco Stock Highlights
Elanco Animal Health (ELAN) is traded on New York Stock Exchange in USA. It is located in 2500 Innovation Way, Greenfield, IN, United States, 46140 and employs 9,000 people. Elanco Animal is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.31 B. Elanco Animal Health conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 496.65 M outstanding shares of which 24.28 M shares are currently shorted by private and institutional investors with about 4.03 trading days to cover.
Elanco Animal Health currently holds about 463 M in cash with 541 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.98.
Check Elanco Animal Probability Of Bankruptcy
Ownership AllocationThe majority of Elanco Animal Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Elanco Animal Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Elanco Animal. Please pay attention to any change in the institutional holdings of Elanco Animal Health as this could imply that something significant has changed or is about to change at the company.
Check Elanco Ownership Details
Elanco Animal Health Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Elanco Animal market risk premium is the additional return an investor will receive from holding Elanco Animal long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.3131 | |||
| Jensen Alpha | 0.701 | |||
| Total Risk Alpha | 0.5413 | |||
| Sortino Ratio | 0.2774 |
Elanco Stock Against Markets
Elanco Animal Corporate Directors
| Joshua Smiley | Independent Director | Profile | |
| Carl McMillian | Independent Director | Profile | |
| Denise ScotsKnight | Independent Director | Profile | |
| Kirk McDonald | Independent Director | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.